Welcome to LookChem.com Sign In|Join Free
  • or
1-(4-Chloro-phenyl)-2-isopropylamino-ethanol, commonly known as Propofol, is a sedative-hypnotic drug primarily used for the induction and maintenance of general anesthesia, as well as for sedation in intensive care units. It is a white, viscous liquid that is administered intravenously and works by enhancing the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) in the brain, leading to sedative and hypnotic effects. Propofol is known for its quick onset and offset of action, making it a popular choice for anesthesia induction and short-term sedation.
Used in Anesthesia:
1-(4-Chloro-phenyl)-2-isopropylamino-ethanol is used as an anesthetic agent for the induction and maintenance of general anesthesia during surgical procedures. Its quick onset and offset of action, along with its ability to enhance the inhibitory neurotransmitter GABA, make it a popular choice for this application.
Used in Intensive Care Units:
1-(4-Chloro-phenyl)-2-isopropylamino-ethanol is used as a sedative agent in intensive care units for patients who require prolonged sedation. Its sedative and hypnotic effects, achieved through the enhancement of GABA, make it suitable for this purpose.

23299-13-0

Post Buying Request

23299-13-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

23299-13-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 23299-13-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,3,2,9 and 9 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 23299-13:
(7*2)+(6*3)+(5*2)+(4*9)+(3*9)+(2*1)+(1*3)=110
110 % 10 = 0
So 23299-13-0 is a valid CAS Registry Number.
InChI:InChI=1/C11H16ClNO/c1-8(2)13-7-11(14)9-3-5-10(12)6-4-9/h3-6,8,11,13-14H,7H2,1-2H3

23299-13-0 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H50756)  1-(4-Chlorophenyl)-2-(isopropylamino)ethanol, 98%   

  • 23299-13-0

  • 250mg

  • 853.0CNY

  • Detail
  • Alfa Aesar

  • (H50756)  1-(4-Chlorophenyl)-2-(isopropylamino)ethanol, 98%   

  • 23299-13-0

  • 1g

  • 3071.0CNY

  • Detail

23299-13-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(4-chlorophenyl)-2-(propan-2-ylamino)ethanol

1.2 Other means of identification

Product number -
Other names (+/-)-p-Chloroisoproterenol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:23299-13-0 SDS

23299-13-0Relevant academic research and scientific papers

Continuous and convergent access to vicinyl amino alcohols

Nobuta, Tomoya,Xiao, Guozhi,Ghislieri, Diego,Gilmore, Kerry,Seeberger, Peter H.

, p. 15133 - 15136 (2015/10/12)

Five active pharmaceutical ingredients (APIs) containing the vicinyl amino alcohol moiety were synthesized using a convergent chemical assembly system. The continuous system is composed of four flow reaction modules: biphasic oxidation, Corey-Chaykovsky epoxidation, phenol alkylation, and epoxide aminolysis. Judicious choice of reagents and module order allowed for two classes of β-amino alcohols, aryl and aryloxy, to be synthesized in good (27-69%) overall yields.

5H-CYCLOPENTA[D]PYRIMIDINES AS AKT PROTEIN KINASE INHIBITORS

-

Page/Page column 63-64, (2009/09/04)

Compounds of Formula I are useful for inhibiting AKT protein kinases. Methods of using compounds of Formula I and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed. Formula (I).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 23299-13-0